56882-77-0

Usage

Uses

Used in Pharmaceutical Industry:
4-thiadiazole,2-amino-5-cyclohexyl-3 is used as a pharmaceutical compound for its antimicrobial, antifungal, and anti-inflammatory properties. Its unique structure and biological activities make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Antimicrobial Applications:
4-thiadiazole,2-amino-5-cyclohexyl-3 is used as an antimicrobial agent to combat various types of bacteria. Its ability to inhibit bacterial growth makes it a valuable component in the development of new antibiotics and antimicrobial treatments.
Used in Antifungal Applications:
4-thiadiazole,2-amino-5-cyclohexyl-3 is used as an antifungal agent to treat fungal infections. Its effectiveness against various fungal species highlights its potential in the creation of new antifungal medications.
Used in Anti-inflammatory Applications:
4-thiadiazole,2-amino-5-cyclohexyl-3 is used as an anti-inflammatory agent to reduce inflammation and alleviate symptoms associated with inflammatory conditions. Its potential to modulate inflammatory responses makes it a candidate for the development of new anti-inflammatory drugs.
Research on 4-thiadiazole,2-amino-5-cyclohexyl-3 continues to explore its potential uses and benefits in various fields, including drug development and pharmaceutical applications. Its unique structure and biological properties position it as a promising compound for future advancements in medicine.

InChI:InChI=1/C8H13N3S/c9-8-11-10-7(12-8)6-4-2-1-3-5-6/h6H,1-5H2,(H2,9,11)

Upstream product

• 79-19-6 thiosemicarbazide 
• 2719-27-9 cyclohexanylcarbonyl chloride 
• 2043-61-0 cyclohexanecarbaldehyde 
• 255715-64-1 2-(cyclohexylmethylidene)hydrazinecarbothioamide 
• 98-89-5 Cyclohexanecarboxylic acid 

Downstream Products

• 497079-04-6 1-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-3-(3,4-dichlorophenyl)urea 
• 1000383-58-3 C₁₈H₁₉N₃O₂S 
• 1000383-57-2 C₁₈H₁₉N₃OS 
• 1000383-56-1 C₁₇H₁₆ClN₃OS 
• 879859-60-6 2-cyclohexyl-6-(4-bromophenyl)imidazo[2,1-b][1,3,4]thiadiazole 
• 105613-25-0 2-Bromo-5-cyclohexyl-1,3,4-thiadiazole 
• 83390-43-6 3-cyclohexyl-6,8-dibromo-2--4(3H)-quinazolone 
• 83390-37-8 N-(5-Cyclohexyl-[1,3,4]thiadiazol-2-yl)-2-[6,8-dibromo-3-(2-ethyl-phenyl)-4-oxo-3,4-dihydro-quinazolin-2-ylsulfanyl]-acetamide 
• 83390-39-0 N-(5-Cyclohexyl-[1,3,4]thiadiazol-2-yl)-2-[6,8-dibromo-3-(4-methoxy-phenyl)-4-oxo-3,4-dihydro-quinazolin-2-ylsulfanyl]-acetamide 
• 83390-34-5 6-bromo-3-cyclohexyl-2--4(3H)-quinazolone 
• 83390-36-7 N-(5-Cyclohexyl-[1,3,4]thiadiazol-2-yl)-2-(6,8-dibromo-4-oxo-3-o-tolyl-3,4-dihydro-quinazolin-2-ylsulfanyl)-acetamide 

Relevant academic research and scientific papers

Novel 1,3,4-thiadiazole conjugates derived from protocatechuic acid: Synthesis, antioxidant activity, and computational and electrochemical studies

A series of 15 novel 1,3,4-thiadiazole amide derivatives containing a protocatechuic acid moiety were synthesized and structurally characterized. In addition, the corresponding imino (4) and amino (5) analogues of a phenyl-substituted 1,3,4-thiadiazole am

PhI-Catalyzed Intramolecular Oxidative Coupling Toward Synthesis of 2-Amino-1,3,4-Thiadizoles

A highly efficient method for the synthesis of thiadiazole derivatives via intramolecular oxidative coupling of thiosemicarbazide, using the in situ generated hypervalent iodine(III) reagents is developed. The protocol can be carried out smoothly and provides a variety of thiadiazole derivatives in moderate to excellent yields. Graphical Abstract: A highly efficient method for the synthesis of thiadiazole derivatives via PhI-catalyzed intramolecular oxidative coupling of thiosemicarbazide has been developed.

Synthesis and evaluation of novel 1,3,4-thiadiazole–fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents

A series of 5-substituted-1,3,4-thiadiazole-based fluoroquinolone derivatives were designed as potential antibacterial and anticancer agents using a molecular hybridization approach. The target compounds 16–25 were synthesized by reacting the correspondin

IL-8 RECEPTOR ANTAGONISTS

This invention relates to novel compounds, compositions and combinations thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

Thiadiazole derivatives active on the central nervous system and pharmaceutical compositions

The invention relates to thiadiazole derivatives corresponding to the formula: STR1 in which R represents: a linear or branched alkyl group having from 1 to 5 carbon atoms; a cycloalkyl group having 5 or 6 carbon atoms; a phenyl group optionally substitut